
Jonathan S. Lau
Examiner (ID: 8893, Phone: (571)270-3531 , Office: P/1673 )
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1693, 1623, 1673 |
| Total Applications | 1249 |
| Issued Applications | 700 |
| Pending Applications | 107 |
| Abandoned Applications | 463 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18287300
[patent_doc_number] => 20230102772
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => AMORPHOUS MIXTURE COMPRISING A NEUTRAL MONO- OR OLIGOSACCHARIDE AND AN ACIDIC NON-CARBOHYDRATE COMPONENT
[patent_app_type] => utility
[patent_app_number] => 18/057360
[patent_app_country] => US
[patent_app_date] => 2022-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5736
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18057360
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/057360 | Amorphous mixture comprising a neutral mono- or oligosaccharide and an acidic non-carbohydrate component | Nov 20, 2022 | Issued |
Array
(
[id] => 19884210
[patent_doc_number] => 12269903
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-04-08
[patent_title] => Compositions comprising glucose and hemicellulose and their use
[patent_app_type] => utility
[patent_app_number] => 17/985583
[patent_app_country] => US
[patent_app_date] => 2022-11-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 37611
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 118
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17985583
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/985583 | Compositions comprising glucose and hemicellulose and their use | Nov 10, 2022 | Issued |
Array
(
[id] => 19642898
[patent_doc_number] => 20240417418
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-19
[patent_title] => DISULFIDE OLIGOSACCHARIDE COMPOUNDS AND COMPLEXES
[patent_app_type] => utility
[patent_app_number] => 18/702855
[patent_app_country] => US
[patent_app_date] => 2022-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27934
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -42
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18702855
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/702855 | DISULFIDE OLIGOSACCHARIDE COMPOUNDS AND COMPLEXES | Oct 20, 2022 | Pending |
Array
(
[id] => 20121691
[patent_doc_number] => 20250236722
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-07-24
[patent_title] => SUGAR BEET PECTIN
[patent_app_type] => utility
[patent_app_number] => 18/697744
[patent_app_country] => US
[patent_app_date] => 2022-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1263
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18697744
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/697744 | SUGAR BEET PECTIN | Oct 12, 2022 | Pending |
Array
(
[id] => 18619145
[patent_doc_number] => 11752167
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2023-09-12
[patent_title] => Ophthalmic suspension vehicles and related methods for pharmaceutical ingredient delivery
[patent_app_type] => utility
[patent_app_number] => 17/939606
[patent_app_country] => US
[patent_app_date] => 2022-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 15740
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 148
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17939606
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/939606 | Ophthalmic suspension vehicles and related methods for pharmaceutical ingredient delivery | Sep 6, 2022 | Issued |
Array
(
[id] => 18093197
[patent_doc_number] => 20220411538
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-29
[patent_title] => CELLULOSE ESTER COMPOSITIONS DERIVED FROM RECYCLED PLASTIC CONTENT SYNGAS
[patent_app_type] => utility
[patent_app_number] => 17/819963
[patent_app_country] => US
[patent_app_date] => 2022-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 58056
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17819963
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/819963 | CELLULOSE ESTER COMPOSITIONS DERIVED FROM RECYCLED PLASTIC CONTENT SYNGAS | Aug 15, 2022 | Abandoned |
Array
(
[id] => 18243508
[patent_doc_number] => 20230075819
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-09
[patent_title] => METHODS OF TREATING TUMOR METASTASIS
[patent_app_type] => utility
[patent_app_number] => 17/884798
[patent_app_country] => US
[patent_app_date] => 2022-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26869
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17884798
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/884798 | Methods of treating tumor metastasis | Aug 9, 2022 | Issued |
Array
(
[id] => 20083667
[patent_doc_number] => 20250213603
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-07-03
[patent_title] => PHARMACEUTICAL COMPOSITION FOR TREATING CANCER
[patent_app_type] => utility
[patent_app_number] => 18/292779
[patent_app_country] => US
[patent_app_date] => 2022-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3478
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18292779
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/292779 | PHARMACEUTICAL COMPOSITION FOR TREATING CANCER | Jul 28, 2022 | Pending |
Array
(
[id] => 18003519
[patent_doc_number] => 20220362285
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-17
[patent_title] => WATER-ACTIVATED MUCOADHESIVE COMPOSITIONS TO REDUCE INTESTINAL ABSORPTION OF NUTRIENTS
[patent_app_type] => utility
[patent_app_number] => 17/875831
[patent_app_country] => US
[patent_app_date] => 2022-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16664
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17875831
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/875831 | Water-activated mucoadhesive compositions to reduce intestinal absorption of nutrients | Jul 27, 2022 | Issued |
Array
(
[id] => 18279884
[patent_doc_number] => 20230095356
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => PHARMACEUTICAL COMPOSITION COMPRISING ADENOSINE DERIVATIVE FOR PREVENTION AND TREATMENT OF RETINAL DISEASE OR OPTIC NERVE DISEASE
[patent_app_type] => utility
[patent_app_number] => 17/866990
[patent_app_country] => US
[patent_app_date] => 2022-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8361
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 109
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17866990
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/866990 | Pharmaceutical composition comprising adenosine derivative for prevention and treatment of retinal disease or optic nerve disease | Jul 17, 2022 | Issued |
Array
(
[id] => 18003673
[patent_doc_number] => 20220362439
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-17
[patent_title] => COMPOSITION COMPRISING HYALURONIC ACID AND MEPIVACAINE
[patent_app_type] => utility
[patent_app_number] => 17/862711
[patent_app_country] => US
[patent_app_date] => 2022-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7783
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17862711
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/862711 | COMPOSITION COMPRISING HYALURONIC ACID AND MEPIVACAINE | Jul 11, 2022 | Pending |
Array
(
[id] => 19354079
[patent_doc_number] => 12054508
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2024-08-06
[patent_title] => Compositions and methods for sulfation of carbohydrates and peptides via electron-deficient aryl sulfate diesters
[patent_app_type] => utility
[patent_app_number] => 17/863347
[patent_app_country] => US
[patent_app_date] => 2022-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 25
[patent_no_of_words] => 33898
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17863347
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/863347 | Compositions and methods for sulfation of carbohydrates and peptides via electron-deficient aryl sulfate diesters | Jul 11, 2022 | Issued |
Array
(
[id] => 18003506
[patent_doc_number] => 20220362272
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-17
[patent_title] => MEDICAMENT FOR PREVENTION OR TREATMENT OF RHINOVIRUS INFECTION
[patent_app_type] => utility
[patent_app_number] => 17/811488
[patent_app_country] => US
[patent_app_date] => 2022-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4099
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17811488
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/811488 | Medicament for prevention or treatment of rhinovirus infection | Jul 7, 2022 | Issued |
Array
(
[id] => 18003518
[patent_doc_number] => 20220362284
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-17
[patent_title] => TREATMENT OF BONE MARROW EDEMA (OEDEMA) WITH POLYSULFATED POLYSACCHARIDES
[patent_app_type] => utility
[patent_app_number] => 17/857420
[patent_app_country] => US
[patent_app_date] => 2022-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6817
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17857420
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/857420 | TREATMENT OF BONE MARROW EDEMA (OEDEMA) WITH POLYSULFATED POLYSACCHARIDES | Jul 4, 2022 | Abandoned |
Array
(
[id] => 19387869
[patent_doc_number] => 20240277739
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-22
[patent_title] => NUTRITONAL COMPOSITIONS FOR GUT BARRIER FUNCTION
[patent_app_type] => utility
[patent_app_number] => 18/570652
[patent_app_country] => US
[patent_app_date] => 2022-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14365
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18570652
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/570652 | NUTRITONAL COMPOSITIONS FOR GUT BARRIER FUNCTION | Jun 30, 2022 | Pending |
Array
(
[id] => 19291562
[patent_doc_number] => 12030908
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-07-09
[patent_title] => Antimicrobial compounds, compositions, and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/856537
[patent_app_country] => US
[patent_app_date] => 2022-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 35351
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17856537
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/856537 | Antimicrobial compounds, compositions, and uses thereof | Jun 30, 2022 | Issued |
Array
(
[id] => 18280677
[patent_doc_number] => 20230096149
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => Reagents Useful for Synthesizing Rhodamine-Labeled Oligonucleotides
[patent_app_type] => utility
[patent_app_number] => 17/854220
[patent_app_country] => US
[patent_app_date] => 2022-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19182
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17854220
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/854220 | Reagents Useful for Synthesizing Rhodamine-Labeled Oligonucleotides | Jun 29, 2022 | Abandoned |
Array
(
[id] => 18664849
[patent_doc_number] => 11771714
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2023-10-03
[patent_title] => Ophthalmic suspension vehicles and related methods for pharmaceutical ingredient delivery
[patent_app_type] => utility
[patent_app_number] => 17/854680
[patent_app_country] => US
[patent_app_date] => 2022-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 15731
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 115
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17854680
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/854680 | Ophthalmic suspension vehicles and related methods for pharmaceutical ingredient delivery | Jun 29, 2022 | Issued |
Array
(
[id] => 19402127
[patent_doc_number] => 20240285638
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-29
[patent_title] => METHODS FOR TREATING FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY (FSHD)
[patent_app_type] => utility
[patent_app_number] => 18/573684
[patent_app_country] => US
[patent_app_date] => 2022-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13135
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18573684
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/573684 | METHODS FOR TREATING FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY (FSHD) | Jun 23, 2022 | Pending |
Array
(
[id] => 18128850
[patent_doc_number] => 11555049
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-01-17
[patent_title] => Method for separation and purification of n-acetylglucosamine
[patent_app_type] => utility
[patent_app_number] => 17/844994
[patent_app_country] => US
[patent_app_date] => 2022-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6927
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 229
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17844994
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/844994 | Method for separation and purification of n-acetylglucosamine | Jun 20, 2022 | Issued |